Sollis Therapeutics, Inc.

The recent partial success of Vertex Pharmaceuticals Incorporated ’s non-opioid product VX-548 in a pair of acute pain studies positions the product as potentially the first new non-opioid analgesic

Derived from Strategic Transactions , Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging bioph

Start-up RallyBio Inc. , which launched on April 25 with $37m in Series A venture capital, is starting out with a dream team of executives with experience developing, launching and marketing therapie